Transformative Partnership in Biomaterial Development
PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) has embarked on an exciting journey in the field of biomaterials by entering into a Master Services Agreement with PiezoBioMembrane, Inc. This agreement signifies a robust collaboration aimed at merging their combined knowledge and resources for the development of innovative functional biomaterials intended for a broad spectrum of medical applications.
Collaboration Details
Under this partnership, both PetVivo and PiezoBio will focus on developing a novel piezo-biomaterial. This new material will utilize PetVivo’s existing expertise in biocompatible biomaterials that resemble mammalian extracellular matrix (ECM) along with PiezoBio's leading-edge piezoelectric nanofibers. The goal is to create biomaterials that not only integrate seamlessly with existing tissues but can also be activated biologically, thereby enhancing healing and regeneration processes.
Advancements in Biocompatible Biomaterials
PetVivo has pioneered the creation of a biocompatible biomaterial that closely mimics natural mammalian tissues. This innovation is significant because it reduces the risk of adverse effects when implanted in animals or humans. PetVivo's biocompatible ECM-like products have profound implications for restorative therapies in veterinary medicine.
SPRYNG™ with OsteoCushion™ Technology
One of the key products stemming from PetVivo’s research is SPRYNG™ with OsteoCushion™ Technology. This veterinary medical device is an injectable solution composed of matrix microparticles that has demonstrated the ability to absorb into an animal’s joint structure. By promoting the restoration of proper joint mechanics, SPRYNG™ aids in alleviating non-infectious joint pain caused by various conditions, including osteoarthritis and degenerative joint disease.
Visionary Goals for Regenerative Medicine
Mike Eldred, a Board Member at PetVivo Holdings, stated that the collaborative efforts between PetVivo and PiezoBio aim to spearhead the next generation of biomaterials. These materials, developed using natural components found in mammalian ECM, are set to transform the landscape of regenerative therapies. Leveraging expertise from both companies could significantly advance innovative medical devices and therapies that promise better outcomes for veterinarians and their patients.
PiezoBio's Unique Technologies
PiezoBio brings to the table a groundbreaking biodegradable piezoelectric nanomaterial. This material is designed to operate as a battery-free electrical stimulator, which promotes cell activity once implanted within animal tissues or bones. This unique technology provides an innovative approach to tissue and bone regeneration, allowing for wireless and self-stimulated healing solutions.
Diverse Applications Beyond Veterinary Medicine
The potential applications for the biomaterials developed through this partnership extend far beyond veterinary medicine. Linh Le, CEO of PiezoBioMembrane, emphasized the collective aim to explore therapeutic areas beyond piezoelectric materials to maximize their impact on health. By harnessing open innovation, both companies aspire to accelerate their product development to address diverse health challenges effectively.
PetVivo's Commitment to Animal Health
PetVivo Holdings operates with a focus on improving veterinary care through its advanced products. Their strategies include leveraging human medical therapies for prompt adaptation to animal health needs. Consequently, this not only allows for faster revenue generation but also positions PetVivo as a leader in the biomedical device sector aimed at companion animals.
About PetVivo and PiezoBioMembrane
PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) is dedicated to advancing innovative medical devices tailored for the health of companion animals. Their patented technologies ensure compliance with rigorous standards while prioritizing animal welfare.
On the other hand, PiezoBioMembrane, Inc. pioneers research in piezoelectric biomaterials, focusing on delivering effective healthcare solutions. They are backed by a commitment to innovation that stems from their origins in academic research, ensuring that they constantly push the boundaries of what's possible in healthcare technology.
Frequently Asked Questions
What is the significance of the partnership between PetVivo and PiezoBio?
The partnership aims to develop innovative biomaterials that enhance healing and regeneration in animal health care.
What products are being developed from this collaboration?
The collaboration will focus on piezoelectric nanofibers combined with PetVivo’s ECM biomaterials, targeting advanced medical applications for animal health.
How does SPRYNG™ with OsteoCushion™ Technology help animals?
SPRYNG™ can restore proper joint mechanics in animals, alleviating pain from joint conditions such as arthritis.
What role does piezoelectric material play in this partnership?
The piezoelectric material developed by PiezoBio acts as a stimulator to promote cell activity and induce tissue regeneration.
How does PetVivo ensure the safety of their products?
PetVivo utilizes biocompatible materials that minimize adverse effects when implanted, prioritizing safety and efficacy in animal health.
